152 related articles for article (PubMed ID: 33090711)
21. PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma.
Shen B; Huang D; Ramsey AJ; Ig-Izevbekhai K; Zhang K; Lajud SA; O'Malley BW; Li D
Br J Cancer; 2020 Mar; 122(5):640-647. PubMed ID: 31853007
[TBL] [Abstract][Full Text] [Related]
22. The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients.
Alemayehu A; Fridrichova I
Eur J Hum Genet; 2007 Sep; 15(9):922-9. PubMed ID: 17534377
[TBL] [Abstract][Full Text] [Related]
23. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.
Dzikiewicz-Krawczyk A
Mutat Res; 2008; 659(3):262-73. PubMed ID: 18606567
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
Li D; Ye L; Lei Y; Wan J; Chen H
BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
[TBL] [Abstract][Full Text] [Related]
25. NBS1 promotes the endonuclease activity of the MRE11-RAD50 complex by sensing CtIP phosphorylation.
Anand R; Jasrotia A; Bundschuh D; Howard SM; Ranjha L; Stucki M; Cejka P
EMBO J; 2019 Apr; 38(7):. PubMed ID: 30787182
[TBL] [Abstract][Full Text] [Related]
26. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment.
Bian L; Meng Y; Zhang M; Li D
Mol Cancer; 2019 Nov; 18(1):169. PubMed ID: 31767017
[TBL] [Abstract][Full Text] [Related]
27. β-Lapachone enhances Mre11-Rad50-Nbs1 complex expression in cisplatin-induced nephrotoxicity.
Kim TW; Kim YJ; Kim HT; Park SR; Jung JY
Pharmacol Rep; 2016 Feb; 68(1):27-31. PubMed ID: 26721347
[TBL] [Abstract][Full Text] [Related]
28. MRN Complex and Cancer Risk: Old Bottles, New Wine.
Elkholi IE; Foulkes WD; Rivera B
Clin Cancer Res; 2021 Oct; 27(20):5465-5471. PubMed ID: 34261697
[TBL] [Abstract][Full Text] [Related]
29. High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.
Altan B; Yokobori T; Ide M; Bai T; Yanoma T; Kimura A; Kogure N; Suzuki M; Bao P; Mochiki E; Ogata K; Handa T; Kaira K; Nishiyama M; Asao T; Oyama T; Kuwano H
Anticancer Res; 2016 Oct; 36(10):5237-5247. PubMed ID: 27798884
[TBL] [Abstract][Full Text] [Related]
30. MRE11 UFMylation promotes ATM activation.
Wang Z; Gong Y; Peng B; Shi R; Fan D; Zhao H; Zhu M; Zhang H; Lou Z; Zhou J; Zhu WG; Cong YS; Xu X
Nucleic Acids Res; 2019 May; 47(8):4124-4135. PubMed ID: 30783677
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Mre11/Rad50 by Nbs1: effects on nucleotide-dependent DNA binding and association with ataxia-telangiectasia-like disorder mutant complexes.
Lee JH; Ghirlando R; Bhaskara V; Hoffmeyer MR; Gu J; Paull TT
J Biol Chem; 2003 Nov; 278(46):45171-81. PubMed ID: 12966088
[TBL] [Abstract][Full Text] [Related]
32. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
Chang L; Huang J; Wang K; Li J; Yan R; Zhu L; Ye J; Wu X; Zhuang S; Li D; Zhang G
BMC Cancer; 2016 Mar; 16():190. PubMed ID: 26951044
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of high glucose-induced mitochondrial DNA damage in retinal ganglion cells.
Zhou J; Chen F; Yan A; Xia X
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):219-224. PubMed ID: 38650130
[TBL] [Abstract][Full Text] [Related]
34. The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity.
Mirzoeva OK; Kawaguchi T; Pieper RO
Mol Cancer Ther; 2006 Nov; 5(11):2757-66. PubMed ID: 17121922
[TBL] [Abstract][Full Text] [Related]
35. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair.
Alt JR; Bouska A; Fernandez MR; Cerny RL; Xiao H; Eischen CM
J Biol Chem; 2005 May; 280(19):18771-81. PubMed ID: 15734743
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.
Schuetz JM; MaCarthur AC; Leach S; Lai AS; Gallagher RP; Connors JM; Gascoyne RD; Spinelli JJ; Brooks-Wilson AR
BMC Med Genet; 2009 Nov; 10():117. PubMed ID: 19917125
[TBL] [Abstract][Full Text] [Related]
37. DNA lesion-specific co-localization of the Mre11/Rad50/Nbs1 (MRN) complex and replication protein A (RPA) to repair foci.
Robison JG; Lu L; Dixon K; Bissler JJ
J Biol Chem; 2005 Apr; 280(13):12927-34. PubMed ID: 15653682
[TBL] [Abstract][Full Text] [Related]
38. A Survey of Reported Disease-Related Mutations in the MRE11-RAD50-NBS1 Complex.
Rahman S; Canny MD; Buschmann TA; Latham MP
Cells; 2020 Jul; 9(7):. PubMed ID: 32668560
[TBL] [Abstract][Full Text] [Related]
39. Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours.
Martin RM; Kerr M; Teo MT; Jevons SJ; Koritzinsky M; Wouters BG; Bhattarai S; Kiltie AE
Oncotarget; 2014 Feb; 5(4):993-1003. PubMed ID: 24625413
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells.
Kavitha CV; Choudhary B; Raghavan SC; Muniyappa K
Biochem Biophys Res Commun; 2010 Sep; 399(4):575-80. PubMed ID: 20682289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
